Anavex Life Sciences Cor
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$8.58avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Anavex Life Sciences Cor in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Byrne Asset Management LLC ($40K).
- Company
- Anavex Life Sciences Cor
- CUSIP
- 032797102
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 3,022 shares bought, net +3,022 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Byrne Asset Management LLC | 0.03% | Add +186.5% | 4,642 | $40K |
"% of holder's portfolio" is ANAVEX LIFE SCIENCES COR's weight in each manager's 13F, not the share of Anavex Life Sciences Cor the manager owns.